The exacerbation of MG is associated with gradual increases in the numbers of GCs and the expression of CXCL13, proportional to changes in the numbers of CD19+ B cells, SMBs and NSMBs1,32,33. The gene discussed is CXCL13; the disease is myasthenia gravis.